Publications

Found 33 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is G  [Clear All Filters]
2017
Gornalusse GG, Hirata RK, Funk SE, Riolobos L, Lopes VS, Manske G, Prunkard D, Colunga AG, Hanafi L-A, Clegg DO et al..  2017.  HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells. Nat Biotechnol.
George MS, Nazari H, Mitra D., Clegg DO, Hinton DR, Humayun MS.  2017.  Scaffolds for Cell Transplantation. Cellular Therapies for Retinal Disease. :45-54.
Rowland TJ, Hinton DR, Freidlander M, Gamm D, Clegg DO.  2017.  Stem Cells and Cellular Therapy. Ryan's Retina.
2016
Leach LL, Croze RH, Hu Q, Nadar VP, Clevenger TN, Pennington BO, Gamm DM, Clegg DO.  2016.  Induced Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium: A Comparative Study Between Cell Lines and Differentiation Methods. J Ocul Pharmacol Ther. 32(5):317-30.
2014
Sowden J, Beebe D, Powell C, Bird A, Cepko C, Clegg DO, Gamm DA, Goldman D, Hitchcock P, Hyde D et al..  2014.  Restoring Vision to the Blind: The Lasker/IRRF Initiative for Innovation in Vision Science.. Transl Vis Sci Technol. 3(7):1.
Sowden J, Beebe D, Powell C, Bird A, Cepko C, Clegg DO, Gamm DA, Goldman D, Hitchcock P, Hyde D et al..  2014.  Restoring Vision to the Blind: The Lasker/IRRF Initiative for Innovation in Vision Science.. Transl Vis Sci Technol. 3(7):1.
2012
Piunova V, Patel P, Lee C, Tsie M, Grubbs RH, Clegg DO.  2012.  Biodegradable polymer scaffolds for stem-cell based treatment of age-related macular degeneration.
Gupta N, Lin BF, Campos LM, Dimitriou MD, Hikita ST, Treat ND, Tirrell MV, Clegg DO, Kramer EJ, Hawker CJ.  2012.  A versatile approach to high-throughput microarrays using thiol-ene chemistry. Nature Chemistry. 4:424–424.
2011
Ahuja A, Clegg D, Grubbs R, Hinton D, Humayun M, Tai YC.  2011.  Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same.
Humayun M, Ahuja A, Tai Y-C, Hinton D, Grubbs R, Clegg D, JOHNSON LVallance, Hikita ST, .  2011.  Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same.
2010
Gupta N, Lin BF, Campos LM, Dimitriou MD, Hikita ST, Treat ND, Tirrell MV, Clegg DO, Kramer EJ, Hawker CJ.  2010.  A versatile approach to high-throughput microarrays using thiol-ene chemistry. Nature Chemistry. 2(2):138-45.
2009
Carr A-J, Vugler AA, Hikita ST, Lawrence JM, Gias C, Chen LLi, Buchholz DE, Ahmado A, Semo M'ayan, Smart MJK et al..  2009.  Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One. 4(12):e8152.
2008
Gupta N, Campos LM, Hikita ST, Guino RG, Dimitriou MD, Given ELK, Clegg DO, Hawker CJ.  2008.  Thiol-ene hydrogels for cell culture and stem cell differentiation. Abstracts of Papers of the American Chemical Society. 235
Gupta N, Campos LM, Hikita ST, Guino RG, Dimitriou MD, Given ELK, Clegg DO, Hawker CJ.  2008.  Thiol-ene hydrogels for cell culture and stem cell differentiation. Abstracts of Papers of the American Chemical Society. 235
Gupta N, Campos LM, Hikita ST, Guino RG, Dimitriou MD, Given ELK, Clegg DO, Hawker CJ.  2008.  Thiol-ene hydrogels for cell culture and stem cell differentiation. Abstracts of Papers of the American Chemical Society. 235
2006
Hikita ST, Vistica BP, Jones HR, Keswani JR, Watson MM, Ericson VR, Ayoub GS, Gery I, Clegg DO.  2006.  Osteopontin is proinflammatory in experimental autoimmune uveitis. Investigative Ophthalmology & Visual Science. 47(10):4435-43.
Gupta N, Vestberg R, Malkoch M, Hikita S, Thibault R, Lingwood M, McCarney E, Han S-I, Clegg D, Hawker CJ.  2006.  POLY 415-Characterization of poly (ethylene glycol) hydrogels formed via Click chemistry. Abstracts of Papers of the American Chemincal Society. 232
2005
Hikita ST, Vistica BP, Watson MM, Gery I, Clegg DO.  2005.  Investigation of the Pro-Inflammatory Function of Osteopontin in Experimental Autoimmune Uveitis. Investigative Ophtalmology & Visual Science. 46:993.
2004
Wingerd KL, Goodman NL, Leu ST, Clegg DO.  2004.  Expression and function of integrin alpha4beta1 and vascular cell adhesion molecule-1 (VCAM-1) during sympathetic innervation of the heart. Developmental Dynamics. 231(2):359-69.
Leu ST, Jacques SAL, Wingerd KL, Hikita ST, Tolhurst EC, Pring JL, Wiswell D, Kinney L, Goodman NL, Jackson DY et al..  2004.  Integrin alpha4beta1 function is required for cell survival in developing retina. Developmental Biology. 276(2):416-30.
Hikita ST, Vistica BP, Gery I, Clegg DO.  2004.  Investigation of the pro-inflammatory function of osteopontin in retinal autoimmune disease. Molecular Biology of the Cell. 15:302A–303A.
2002
Wingerd KL, Goodman NL, Tresser JW, Smail MM, Leu ST, Rohan SJ, Pring JL, Jackson DY, Clegg DO.  2002.  Alpha4 integrins and vascular cell adhesion molecule-1 play a role in sympathetic innervation of the heart. The Journal of Neuroscience. 22(24):10772-80.
Clegg DO, Leu ST, Jacques S, Wingerd KL, Goodman N.  2002.  Inhibition of integrin alpha4/beta1 in developing chick retina results in increased apoptosis. Molecular Biology of the Cell. 13:482A–483A.
Mey A, Gandrillon O, McNagny KM, Clegg DO, Samarut J.  2002.  The v-erbA oncogene blocks expression of alpha2/beta1 integrin a normal inhibitor of erythroid progenitor proliferation. Oncogene. 21(18):2864-72.
2001
Wingerd KL, Goodman N, Leu ST, Smail M, Rohan SX, Clegg DO.  2001.  Alpha4 integrins and vascular cell adhesion molecule-1 play a role in sympathetic innervation of the heart. Molecular Biology of the Cell. 12:319A–320A.

Pages